In June 2017, Yin et al. reported a third plasmid-borne colistin resistance gene (encoded by *mcr-3*) in *Escherichia coli* from China \[[@r1]\]. The same study identified a truncated transposon element immediately upstream of *mcr-3* that was also found in *E. coli*, *Klebsiella pneumoniae* and *Salmonella* Typhimurium \[[@r1]\]. This followed reports from 2016 on the plasmid-borne colistin resistance genes *mcr-1* \[[@r2]\] and *mcr-2* \[[@r3]\] and the subsequent reporting of global spread of *mcr-1* and detection of *mcr-1* from livestock/retail meat and human sources \[[@r4],[@r5]\]. The worldwide spread of plasmid-mediated colistin resistance is of major concern, as colistin in some instances is the drug of last resort for multidrug-resistant infections.

Detection of *mcr-3*-positive human clinical isolates in Denmark
================================================================

Statens Serum Institut (SSI) receives isolates (originating from stool, blood or urine samples) and patient information from all human clinical *Salmonella* infections for surveillance in Denmark. Since January 2017, all *Salmonella* isolates have been subjected to whole genome sequencing (WGS) in real time, in contrast to previous years where only a selection of isolates were sequenced. In a retrospective search for the truncated transposon and *mcr-3* \[[@r1]\] among all Danish *Salmonella* isolates sequenced at SSI between 2009 and 2017 (ca 2,500), 10 *Salmonella* isolates were found positive for the *mcr-3* gene; all isolates were ST34 and of serovar Typhimurium or monophasic variants of Typhimurium (4,5,12:i:- and 4,12:i:-) ([Table](#t1){ref-type="table"}). The years of disease onset recorded for the 10 Salmonella isolates were 2009 (n = 1), 2010 (n = 1), 2011 (n = 2), 2012 (n = 3), 2015 (n = 1), 2016 (n = 1) and 2017 (n = 1). Four of the patients had travelled to Thailand and one to Vietnam before onset of disease, three patients had unknown travel history and two patients had acquired their infection domestically ([Table](#t1){ref-type="table"}).

###### *Salmonella* isolates positive for *mcr-3*, Denmark, 2009--17 (n=10)

  Isolate     Year of isolation   Serotype          Travel reported   Inc type                                        Resistance genes detected by ResFinder besides *mcr-3*
  ----------- ------------------- ----------------- ----------------- ----------------------------------------------- ------------------------------------------------------------------------------------------
  SSI-AC256   2009                Typhimurium       None              IncA/C2, ColRNAI                                *aac(3)-IId, bla~CTX-M-55~, bla~TEM-1B~, catA2, floR, qnrS1, strA, strB, sul2, tet*(A)
  SSI-AC257   2010                O:4,5,12; H:i:-   Unknown           IncA/C2, ColRNAI                                *aac(3)-IId, bla~CTX-M-55~, bla~TEM-1B~, floR, qnrS1, strA, strB, sul2, tet*(A)
  SSI-AC259   2011                O:4,5,12; H:i:-   Thailand          IncFII, IncQ1                                   *aac(3)-IId, bla~CTX-M-55~, bla~TEM-1B~, catA2, qnrS1, strA, strB, sul2, tet*(B)
  SSI-AC258   2011                O:4,5,12; H:i:-   Thailand          IncA/C2                                         *aac(3)-IId, bla~CTX-M-55~, bla~TEM-1B~, catA2, floR, qnrS1, strA, strB, sul2, tet*(A)
  SSI_AA940   2012                Typhimurium       None              ColRNAI                                         *aac(3)-IId, bla~CTX-M-55~, catA2, floR, qnrS1, strA, strB, sul2, tet(A)*
  SSI_AA992   2012                O:4,12; H:i: -    Unknown           IncHI2A, IncHI2, IncN, TrfA, IncQ1, ColRNAI     *aadA2, aph(3\')-Ic, bla~TEM-1B~, dfrA12, strA, strB, sul1, sul2, tet[(]{.ul}A), tet(B)*
  SSI_AA934   2012                Typhimurium       Thailand          IncA/C2, ColRNAI                                *aac(3)-IId, bla~CTX-M-55~, bla~TEM-1B~, catA2, floR, qnrS1, strA, strB, sul2, tet*(A)
  SSI-AC260   2015                O:4,12; H:i: -    Vietnam           IncA/C2                                         *bla~CTX-M-55~, bla~TEM-1B~, floR, strA, strB, sul2, tet*(A)
  SSI-AC261   2016                O:4,5,12; H:i:-   Thailand          IncFII(pCoo), IncX1, Col(MP18), IncQ1,ColRNAI   *bla~TEM-1B~, strA, strB, sul2, tet*(B)
  SSI-AC262   2017                O:4,12; H:i: -    Unknown           IncFIC(FII), IncI2, IncA/C2                     *bla~CTX-M-55~, bla~TEM-1B~, floR, mcr-1, strA, strB, sul2, tet*(A)

Single-nucleotide polymorphism-based phylogeny
==============================================

From WGS data (Illumina MiSeq) of the 10 *mcr-3* positive isolates, extraction of sequences types (<http://enterobase.warwick.ac.uk>) assigned all isolates to ST34 ([Table](#t1){ref-type="table"}). The sequence data was used to create a single-nucleotide polymorphism (SNP) phylogeny using the Northern Arizona SNP Pipeline (NASP) \[[@r6]\], including local sequences representing the diversity within ST34 isolated from patients in Denmark with different travel histories ([Figure](#f1){ref-type="fig"}). In total, 361 *Salmonella* isolates with serotypes Typhimurium and the monophasic variants of Typhimurium were included in the SNP analysis and the 10 *mcr-3*-positive isolates were located in two clades of the phylogeny ([Figure](#f1){ref-type="fig"}). These two clades also contained most of the *Salmonella* isolates from patients with known travel history to Asia. Isolates from patients that had travelled in Europe, were domestically acquired or of unknown origin, were evenly distributed in the tree.

![Phylogenetic tree calculated on core SNPs, including 361 isolates and 2,925 SNPs](eurosurv-22-30587-f1){#f1}

Characterisation of isolates
============================

Using ResFinder (<https://cge.cbs.dtu.dk/services/ResFinder/>), various resistance genes were detected in the WGS data ([Table](#t1){ref-type="table"}). The most prevalent resistance genes found in relation to the monophasic variant of Typhimurium, *bla*~TEM − 1~, *strA-strB, sul2* and *tet*(A) or *tet*(B) \[[@r7]\] were detected in all *mcr-3*-positive isolates in this study. In addition, eight of the isolates carried *bla*~CTX-M-55~ and six isolates contained *qnrS1,* conferring low level resistance to fluoroquinolones \[[@r8]\]. Of note, one isolate from 2017 was positive to both *mcr-1* and *mcr-3* \[[@r2]\]. Using PlasmidFinder (<https://cge.cbs.dtu.dk/services/PlasmidFinder/>), several different replicons were detected ([Table](#t1){ref-type="table"}). One was IncHI2, the same as the plasmid-borne *mcr-3* identified by Yin et al. on a 261-kb IncHI2-type plasmid (pWJ1) \[[@r1]\].

Discussion
==========

The several recent publications that describe new plasmid-mediated colistin resistance \[[@r1]-[@r3]\] are of great concern and underline the importance of monitoring the spread of these plasmids worldwide \[[@r4],[@r5]\]. In Denmark, *mcr-1*-positive isolates from human cases with *Salmonella* infection have been reported \[[@r9]\], whereas *mcr-2* was not found among Danish isolates. This report describes 10 *mcr-3*-positive isolates from human *Salmonella* infections between 2009 and 2017. One of the isolates is especially relevant as it was positive for both *mcr-1* and *mcr-3* and to our knowledge a rare combination of two colistin resistance genes.

Eight of the MCR-3-producing *Salmonella* isolates from the Danish patients were also positive for *bla*~CTX-M-55~. CTX-M-55 was first reported from Thailand \[[@r10]\], and the *bla*~CTX-M-55~ gene is a prevalent gene in Gram-negative bacteria isolated from animals and humans in Asia \[[@r11]-[@r13]\]. Furthermore, *bla*~CTX-M-55~-positive monophasic *Salmonella* Typhimurium has been isolated from patients who reported travel to Thailand \[[@r14]\]. Several other studies have detected isolates with both *mcr-1* and *bla*~CTX-M-55~, most of them also with a link to Asia \[[@r4],[@r15]\]. Half of the Danish *mcr-3*-positive cases were linked with travel to Asia within one week before onset of disease. In general, the level of resistance in the Danish human cases of *Salmonella* Typhimurium and the monophasic variant is higher in cases with travel history than in domestically acquired cases \[[@r16]\].

One of the major concerns with the introduction of plasmid-borne colistin resistance is its ability of rapid horizontal spread between and within bacterial species; therefore plasmid spread could result in an increase in colistin-resistant bacteria. This in combination with the detection of MCR-3-producing isolates in patients without travel history is worrying because *mcr-3* could in the future be present in food-borne outbreaks with *Salmonella* or *E. coli.*
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